Green Pharmaceuticals Inc. issued a voluntary recall of their SnoreStop NasoSpray after FDA testing found the product contaminated with the microbe Providencia rettgeri.
Earlier this week, Green Pharmaceuticals Inc. issued a voluntary recall of their SnoreStop NasoSpray after testing by the US Food and Drug Administration (FDA) found the product to be contaminated with the microbe Providencia rettgeri.
The recalled batches of the nasal spray are lot 2373/21222, packaged in 0.3 FL OZ (9 ml) bottles. The microorganism Providencia rettgeri is rarely implicated in human illness among healthy individuals. However, in immunocompromised persons, using the contaminated product could cause severe or fatal illnesses such as bacteremia/sepsis, pneumonia, invasive fungal rhinosinusitis, and disseminated fungal infection.
Green Pharmaceuticals Inc. noted they have not received any reports of adverse events from consumers of the recalled lot. The affected batch can be identified by a sticker printed with 2373 on the bottom of the bottle and a 21222 sticker on the outer packaging.
SnoreStop NasoSpray is designed to temporarily stop or reduce the symptoms of non-apneic snoring. It is packaged in a single unit plastic bottle, and delivered via a nasal pump. The product was delivered nationwide in health food stores and online, and can be identified by its clear plastic box with the name “SnoreStop NasoSpray.”
Green Pharmaceuticals announced they are emailing retailers and consumers to alert them of the recall. They are also arranging for all recalled products to be returned and replaced. Retailers and customers should cease use of the recalled batch and return to the place of purchase.
Any adverse reactions to this product can be reported via the FDA’s MedWatch Adverse Event Reporting program.
Questions related to this recall can be directed to Green Pharmaceuticals Inc., either by calling 805-388-0600 or emailing firstname.lastname@example.org, Monday-Friday, 8 am-5 pm PST.